Naramune-2 protects dogs and puppies against canine
upper respiratory infections, otherwise known as canine cough or kennel
cough, caused by parainfluenza and Bordetella bronchiseptica. This intranasal vaccine is safe for use in healthy
dogs and puppies as young as 3 weeks of age.
Benefits of Naramune-2:
- Vaccinates against canine parainfluenza and Bordetella bronchiseptica
- Prevents some types of common
respiratory infections and kennel cough
- Helps keep dogs healthy
- Helps protect other animals in
- Protects your dog during boarding
and other circumstances of close contact with other dogs
- Avoids hassles and costs associated
with these illnesses and their treatment
- Administered intranasally, not
Read all label instructions and precautionary statements
prior to use.
For use by or under the close supervision of a veterinarian.
- Reconstitute vaccine with included sterile diluent
to desired volume. For five 0.5-mL doses, rehydrate with 2.5 mL diluent;
for five 1-mL doses, rehydrate with 5 mL diluent.
- Shake well and use product right away.
- Use the manufacturer-provided nasal applicator in
place of syringe needle.
- Administer aseptically via the nasal passage.
Frequency of Use:
Initial vaccination may be made at 3 weeks of age.
Puppies vaccinated before 6 weeks of age should receive a second dose
at this time. Annual boosters are recommended.
Keep out of reach of children and animals.
Refrigerate Naramune-2 between 35 and 45 degrees
F. Do not freeze. Protect from sunlight. Use upon opening.
Incinerate containers and any unused content.
It is a violation of Federal
Law to use this product in a manner inconsistent with its labeling.
Naramune-2 contains modified live virus and avirulent
live culture. It introduces a dog's immune system to canine parainfluenza
and Bordetella bronchiseptica in a controlled manner that elicits a rapid,
effective immune response to these pathogens in the event of subsequent
Naramune-2 contains canine parainfluenza-Bordetella
Bronchiseptica Vaccine, modified live virus, avirulent live culture,
and neomycin as a preservative.
Keep Naramune-2 out of reach of children and animals.
Do not use or store in or near open flame or heat.
Naramune-2 is only intended for administration to
healthy dogs and puppies at least 3 weeks of age. Do not use in younger
puppies or in other species. Not for use in humans.
Follow product and veterinarian directions.
CAUTION: Epinephrine is indicated in
the event of an anaphylactoid reaction.
Very rarely, vaccinated dogs may experience sneezing,
coughing, or nasal discharge for 3 to 10 days following administration.
Antibacterial therapy may be indicated.
Use contents right away upon opening and reconstitution.
Burn containers and unused product.
Warranty and Manufacturer Information:
U.S. Vet. Lic. No.: 124
10423-01 / 10421-01 / 10422-01
NAC No.: 10280791